DSpace Repository

Explaining the benefits of human genome patent

Show simple item record

dc.contributor.author Shahima Akter Topu
dc.date.accessioned 2019-12-06T16:25:01Z
dc.date.available 2019-12-06T16:25:01Z
dc.date.issued 2019-04-12
dc.identifier.citation Shahima Akter Topu. (2019). Explaining the benefits of human genome patent. African Journal of Biological Sciences 1 (2), 46-50. en_US
dc.identifier.issn 2663-2187
dc.identifier.uri http://repository.embuni.ac.ke/handle/embuni/2288
dc.description.abstract Gene patenting has been facing backlash for decades now. Even Michael Crichton, science fiction novelist, as joined the bandwagon speaking against gene patent.1 Such hostility towards patents, the professional interests of academics, researchers and inventors are under the threat of losing their rights over the work they have done. The biotech industry can never be out of discoveries. With constant biological changes, new diseases are appearing and they have to dig deeper. However, not all progress is free. Rewarding the inventors is not at all unfair. This paper will demonstrate that (i) patents are a foundation of the industry. They need to innovate further progress. The reason patent law exists to protect the inventions for a limited period of time. The paper will also demonstrate that (ii) the social myths about gene patent are not really manifested in reality. It will discuss the argument against gene patenting and then will present counter arguments with empirical evidence whether the myths are really true. en_US
dc.language.iso en en_US
dc.publisher African Journal of Biological Sciences en_US
dc.subject Patent system, Concerns, criticisms, Genome patenting, DNA testing en_US
dc.title Explaining the benefits of human genome patent en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Browse

My Account